Status:
COMPLETED
Peds Metabolic Syndrome in Psoriasis
Lead Sponsor:
Tufts Medical Center
Collaborating Sponsors:
Amgen
Conditions:
Psoriasis
Metabolic Syndrome
Eligibility:
All Genders
10-17 years
Brief Summary
The objective of this study is to assess whether there is an increased risk of the metabolic syndrome in children with psoriasis compared to children without psoriasis.
Detailed Description
Adult patients with psoriasis, especially those who are young and with severe disease, have an increased prevalence of myocardial infarction and metabolic syndrome, and increased mortality. Tumor Necr...
Eligibility Criteria
Inclusion
- 10-17 year old children with either moderate to severe psoriasis or with warts
- For psoriasis patients, body surface area covered must be 5% or more or must have had a documented history of 5% or more body surface area involvement
- Ability to understand and sign an age-appropriate consent form
- Parent or Guardian over 18 years old able to understand and sign consent form
Exclusion
- Psoriasis or wart patient younger than 10 or 18 years or older
- For psoriasis patients, body surface area covered less than 5% or have not had a documented history of 5% or more body surface area involvement
- Inability of child or adult parent/guardian to understand or sign consent
- Pregnant or lactating females.
Key Trial Info
Start Date :
April 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT00930592
Start Date
April 1 2009
End Date
December 1 2012
Last Update
April 16 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tufts Medical Center, Department of Dermatology
Boston, Massachusetts, United States, 02111